These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1869596)

  • 21. Pharmacokinetics of tenofovir during pregnancy and postpartum.
    Best BM; Burchett S; Li H; Stek A; Hu C; Wang J; Hawkins E; Byroads M; Watts DH; Smith E; Fletcher CV; Capparelli EV; Mirochnick M;
    HIV Med; 2015 Sep; 16(8):502-11. PubMed ID: 25959631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.
    Vella D; Walker SA; Walker SE; Daneman N; Simor A
    J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.
    Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F
    J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep.
    Möller JC; Gilman JT; Kearns GL; Sussmane JB; Raszynski A; Wolfsdorf J; Reed MD
    Crit Care Med; 1992 Oct; 20(10):1454-8. PubMed ID: 1395668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
    Smyth A; Tan KH; Hyman-Taylor P; Mulheran M; Lewis S; Stableforth D; Prof Knox A;
    Lancet; 2005 Feb 12-18; 365(9459):573-8. PubMed ID: 15708100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition of ornidazole and its metabolites during pregnancy.
    Bourget P; Dechelette N; Fernandez H; Desmaris VQ
    J Antimicrob Chemother; 1995 May; 35(5):691-6. PubMed ID: 7592184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity.
    Olsen KM; Rudis MI; Rebuck JA; Hara J; Gelmont D; Mehdian R; Nelson C; Rupp ME
    Crit Care Med; 2004 Aug; 32(8):1678-82. PubMed ID: 15286543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.
    Conradie F; Zorrilla C; Josipovic D; Botes M; Osiyemi O; Vandeloise E; Eley T; Child M; Bertz R; Hu W; Wirtz V; McGrath D
    HIV Med; 2011 Oct; 12(9):570-9. PubMed ID: 21569187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The place of tobramycin in lower respiratory tract infections (LRTI).
    Gialdroni Grassi G
    J Chemother; 1995 Aug; 7(4):344-54. PubMed ID: 8568545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.
    Dupuis LL; Sung L; Taylor T; Abdolell M; Allen U; Doyle J; Taddio A
    Pharmacotherapy; 2004 May; 24(5):564-73. PubMed ID: 15162890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.
    Colbers A; Moltó J; Ivanovic J; Kabeya K; Hawkins D; Gingelmaier A; Taylor G; Weizsäcker K; Sadiq ST; Van der Ende M; Giaquinto C; Burger D;
    J Antimicrob Chemother; 2015 Feb; 70(2):534-42. PubMed ID: 25326090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nelfinavir plasma concentrations are low during pregnancy.
    Nellen JF; Schillevoort I; Wit FW; Bergshoeff AS; Godfried MH; Boer K; Lange JM; Burger DM; Prins JM
    Clin Infect Dis; 2004 Sep; 39(5):736-40. PubMed ID: 15356791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.
    Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL
    J Antimicrob Chemother; 2017 Jan; 72(1):254-260. PubMed ID: 27585963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population kinetics of tobramycin in neonates.
    Falcão AC; Buelga DS; Méndez ME; García MJ; Pardo M
    Ther Drug Monit; 2001 Jun; 23(3):202-8. PubMed ID: 11360026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of acyclovir in the term human pregnancy and neonate.
    Frenkel LM; Brown ZA; Bryson YJ; Corey L; Unadkat JD; Hensleigh PA; Arvin AM; Prober CG; Connor JD
    Am J Obstet Gynecol; 1991 Feb; 164(2):569-76. PubMed ID: 1847004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.
    Hennig S; Holthouse F; Staatz CE
    Clin Pharmacokinet; 2015 Apr; 54(4):409-21. PubMed ID: 25403847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.